Page last updated: 2024-10-22

amantadine and Sarcoidosis

amantadine has been researched along with Sarcoidosis in 1 studies

amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source

Sarcoidosis: An idiopathic systemic inflammatory granulomatous disorder comprised of epithelioid and multinucleated giant cells with little necrosis. It usually invades the lungs with fibrosis and may also involve lymph nodes, skin, liver, spleen, eyes, phalangeal bones, and parotid glands.

Research Excerpts

ExcerptRelevanceReference
"We report two patients with chronic hepatitis C, both nonresponders to a previous course of interferon (IFN), who developed or suffered an exacerbation of sarcoidosis while under treatment with IFN-alpha2a, ribavirin and amantadine."9.10Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine. ( Lombraña, JL; Pérez-Alvarez, R; Pérez-López, R; Rodrigo, L; Rodríguez, M, 2002)
"We report two patients with chronic hepatitis C, both nonresponders to a previous course of interferon (IFN), who developed or suffered an exacerbation of sarcoidosis while under treatment with IFN-alpha2a, ribavirin and amantadine."5.10Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine. ( Lombraña, JL; Pérez-Alvarez, R; Pérez-López, R; Rodrigo, L; Rodríguez, M, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pérez-Alvarez, R1
Pérez-López, R1
Lombraña, JL1
Rodríguez, M1
Rodrigo, L1

Trials

1 trial available for amantadine and Sarcoidosis

ArticleYear
Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin and amantadine.
    Journal of viral hepatitis, 2002, Volume: 9, Issue:1

    Topics: Adult; Amantadine; Antiviral Agents; Drug Synergism; Female; Hepatitis C, Chronic; Humans; Interfero

2002